Enrichment of human CD4+ Vα24/Vβ11 invariant NKT cells in intrahepatic malignant tumors

Gabriel Bricard, Valerie Cesson, Estelle Devevre, Hanifa Bouzourene, Catherine Barbey, Nathalie Rufer, Jin S. Im, Pedro M. Alves, Olivier Martinet, Nermin Halkic, Jean Charles Cerottini, Pedro Romero, Steven A. Porcelli, H. Robson MacDonald, Daniel E. Speiser

Research output: Contribution to journalArticle

66 Scopus citations

Abstract

Invariant NKT cells (iNKT cells) recognize glycolipid Ags via an invariant TCR α-chain and play a central role in various immune responses. Although human CD4+ and CD4- iNKT cell subsets both produce Th1 cytokines, the CD4+ subset displays an enhanced ability to secrete Th2 cytokines and shows regulatory activity. We performed an ex vivo analysis of blood, liver, and tumor iNKT cells from patients with hepatocellular carcinoma and metastases from uveal melanoma or colon carcinoma. Frequencies of Vα24/Vβ11 iNKT cells were increased in tumors, especially in patients with hepatocellular carcinoma. The proportions of CD4+, double negative, and CD8α+ iNKT cell subsets in the blood of patients were similar to those of healthy donors. However, we consistently found that the proportion of CD4+ iNKT cells increased gradually from blood to liver to tumor. Furthermore, CD4+ iNKT cell clones generated from healthy donors were functionally distinct from their CD4- counterparts, exhibiting higher Th2 cytokine production and lower cytolytic activity. Thus, in the tumor microenvironment the iNKT cell repertoire is modified by the enrichment of CD4+ iNKT cells, a subset able to generate Th2 cytokines that can inhibit the expansion of tumor Ag-specific CD8+ T cells. Because CD4+ iNKT cells appear inefficient in tumor defense and may even favor tumor growth and recurrence, novel iNKT-targeted therapies should restore CD4- iNKT cells at the tumor site and specifically induce Th1 cytokine production from all iNKT cell subsets.

Original languageEnglish (US)
Pages (from-to)5140-5151
Number of pages12
JournalJournal of Immunology
Volume182
Issue number8
DOIs
StatePublished - Apr 15 2009

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Fingerprint Dive into the research topics of 'Enrichment of human CD4+ Vα24/Vβ11 invariant NKT cells in intrahepatic malignant tumors'. Together they form a unique fingerprint.

  • Cite this

    Bricard, G., Cesson, V., Devevre, E., Bouzourene, H., Barbey, C., Rufer, N., Im, J. S., Alves, P. M., Martinet, O., Halkic, N., Cerottini, J. C., Romero, P., Porcelli, S. A., MacDonald, H. R., & Speiser, D. E. (2009). Enrichment of human CD4+ Vα24/Vβ11 invariant NKT cells in intrahepatic malignant tumors. Journal of Immunology, 182(8), 5140-5151. https://doi.org/10.4049/jimmunol.0711086